Outcome of patients aged 60‐75 years with newly diagnosed secondary acute myeloid leukemia: A single‐institution experience

por Bertoli, Sarah, Tavitian, Suzanne, Bories, Pierre, Luquet, Isabelle, Delabesse, Eric, Comont, Thibault, Sarry, Audrey, Huguet, Françoise, Bérard, Emilie, Récher, Christian
Publicado 2019

Improved outcome for AML patients over the years 2000–2014

por Bertoli, Sarah, Tavitian, Suzanne, Huynh, Anne, Borel, Cécile, Guenounou, Sarah, Luquet, Isabelle, Delabesse, Eric, Sarry, Audrey, Laurent, Guy, Attal, Michel, Huguet, Françoise, Bérard, Emilie, Récher, Christian
Publicado 2017

Vitamin C and D supplementation in acute myeloid leukemia

por Mouchel, Pierre Luc, Bérard, Emilie, Tavitian, Suzanne, Gadaud, Noémie, Vergez, François, Rieu, Jean Baptiste, Luquet, Isabelle, Sarry, Audrey, Huguet, Françoise, Largeaud, Laetitia, Delabesse, Eric, Huynh, Anne, Bertoli, Sarah, Récher, Christian
Publicado 2023

Long non-coding RNA expression profile in cytogenetically normal acute myeloid leukemia identifies a distinct signature and a new biomarker in NPM1-mutated patients

por De Clara, Etienne, Gourvest, Morgane, Ma, Hanjing, Vergez, François, Tosolini, Marie, Dejean, Sébastien, Demur, Cécile, Delabesse, Eric, Recher, Christian, Touriol, Christian, Martelli, Maria Paola, Falini, Brunangelo, Brousset, Pierre, Bousquet, Marina
Publicado 2017

PAX5A and PAX5B isoforms are both efficient to drive B cell differentiation

por Cresson, Charlotte, Péron, Sophie, Jamrog, Laura, Rouquié, Nelly, Prade, Nais, Dubois, Marine, Hébrard, Sylvie, Lagarde, Stéphanie, Gerby, Bastien, Mancini, Stéphane J.C., Cogné, Michel, Delabesse, Eric, Delpy, Laurent, Broccardo, Cyril
Publicado 2018

CD34(+)CD38(−)CD123(+) Leukemic Stem Cell Frequency Predicts Outcome in Older Acute Myeloid Leukemia Patients Treated by Intensive Chemotherapy but Not Hypomethylating Agents

por Vergez, François, Nicolau-Travers, Marie-Laure, Bertoli, Sarah, Rieu, Jean-Baptiste, Tavitian, Suzanne, Bories, Pierre, Luquet, Isabelle, De Mas, Véronique, Largeaud, Laetitia, Sarry, Audrey, Huguet, Françoise, Delabesse, Eric, Bérard, Emilie, Récher, Christian
Publicado 2020

GATA2 deficiency phenotype associated with tandem duplication of GATA2 and overexpression of GATA2-AS1

por Singh, Preeti, Heer, Maninder, Resteu, Anastasia, Mikulasova, Aneta, Reza, Mojgan, Largeaud, Laëtitia, Dufrechou, Stéphanie, Prade, Naïs, Dickinson, Rachel E., Bustamante, Jacinta, Neven, Bénédicte, Bigley, Venetia, Delabesse, Eric, Rico, Daniel, Pasquet, Marlène, Collin, Matthew
Publicado 2021

Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes

por Devillier, Raynier, Mansat-De Mas, Véronique, Gelsi-Boyer, Veronique, Demur, Cecile, Murati, Anne, Corre, Jill, Prebet, Thomas, Bertoli, Sarah, Brecqueville, Mandy, Arnoulet, Christine, Recher, Christian, Vey, Norbert, Mozziconacci, Marie-Joelle, Delabesse, Eric, Birnbaum, Daniel
Publicado 2015

Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine

por Bories, Pierre, Prade, Naïs, Lagarde, Stéphanie, Cabarrou, Bastien, Largeaud, Laetitia, Plenecassagnes, Julien, Luquet, Isabelle, De Mas, Véronique, Filleron, Thomas, Cassou, Manon, Sarry, Audrey, Fornecker, Luc-Matthieu, Simand, Célestine, Bertoli, Sarah, Recher, Christian, Delabesse, Eric
Publicado 2020

Genomic landscape of hyperleukocytic acute myeloid leukemia

por Largeaud, Laetitia, Bertoli, Sarah, Bérard, Emilie, Tavitian, Suzanne, Picard, Muriel, Dufrechou, Stéphanie, Prade, Naïs, Vergez, François, Rieu, Jean Baptiste, Luquet, Isabelle, Sarry, Audrey, Huguet, Françoise, Ruiz, Jean, De Mas, Véronique, Delabesse, Eric, Récher, Christian
Publicado 2022

High tumor burden before blinatumomab has a negative impact on the outcome of adult patients with B-cell precursor acute lymphoblastic leukemia. A real-world study by the GRAALL

por Cabannes-Hamy, Aurélie, Brissot, Eolia, Leguay, Thibaut, Huguet, Françoise, Chevallier, Patrice, Hunault, Mathilde, Escoffre-Barbe, Martine, Cluzeau, Thomas, Balsat, Marie, Nguyen, Stéphanie, Pasquier, Florence, Alexis, Magda, Lhéritier, Véronique, Pastoret, Cédric, Delabesse, Eric, Clappier, Emmanuelle, Dombret, Hervé, Boissel, Nicolas
Publicado 2022

Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience

por LaRochelle, Olivier, Bertoli, Sarah, Vergez, François, Sarry, Jean-Emmanuel, Mansat-De Mas, Véronique, Dobbelstein, Sophie, Dastugue, Nicole, Strzelecki, Anne-Claire, Cavelier, Cindy, Creancier, Laurent, Pillon, Arnaud, Kruczynski, Anna, Demur, Cécile, Sarry, Audrey, Huguet, Françoise, Huynh, Anne, Récher, Christian, Delabesse, Eric
Publicado 2011

Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemia

por Ghazavi, Farzaneh, Moerloose, Barbara De, Loocke, Wouter Van, Wallaert, Annelynn, Helsmoortel, Hetty H., Ferster, Alina, Bakkus, Marleen, Plat, Geneviève, Delabesse, Eric, Uyttebroeck, Anne, Nieuwerburgh, Filip Van, Deforce, Dieter, Roy, Nadine Van, Speleman, Frank, Benoit, Yves, Lammens, Tim, Vlierberghe, Pieter Van
Publicado 2016

Interlaboratory Development and Validation of a HRM Method Applied to the Detection of JAK2 Exon 12 Mutations in Polycythemia Vera Patients

por Ugo, Valerie, Tondeur, Sylvie, Menot, Marie-Laurence, Bonnin, Nadine, Le Gac, Gerald, Tonetti, Carole, Mas, Veronique Mansat-De, Lecucq, Lydie, Kiladjian, Jean-Jacques, Chomienne, Christine, Dosquet, Christine, Parquet, Nathalie, Darnige, Luc, Porneuf, Marc, Escoffre-Barbe, Martine, Giraudier, Stephane, Delabesse, Eric, Cassinat, Bruno
Publicado 2010

TET2 Mutations Are Associated with Specific 5-Methylcytosine and 5-Hydroxymethylcytosine Profiles in Patients with Chronic Myelomonocytic Leukemia

por Pérez, Cristina, Martínez-Calle, Nicolas, Martín-Subero, José Ignacio, Segura, Victor, Delabesse, Eric, Fernandez-Mercado, Marta, Garate, Leire, Alvarez, Sara, Rifon, José, Varea, Sara, Boultwood, Jacqueline, Wainscoat, James S., Cigudosa, Juan Cruz, Calasanz, María José, Cross, Nicholas C. P., Prósper, Felipe, Agirre, Xabier
Publicado 2012

Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study

por Dumas, Pierre-Yves, Bertoli, Sarah, Bérard, Emilie, Largeaud, Laetitia, Bidet, Audrey, Delabesse, Eric, Leguay, Thibaut, Leroy, Harmony, Gadaud, Noémie, Rieu, Jean Baptiste, Vial, Jean-Philippe, Vergez, François, Lechevalier, Nicolas, Luquet, Isabelle, Klein, Emilie, Sarry, Audrey, de Grande, Anne-Charlotte, Pigneux, Arnaud, Récher, Christian
Publicado 2020

Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health ca...

por Galtier, Jean, Alric, Camille, Bérard, Emilie, Leguay, Thibaut, Tavitian, Suzanne, Bidet, Audrey, Delabesse, Eric, Rieu, Jean Baptiste, Vial, Jean-Philippe, Vergez, François, Lechevalier, Nicolas, Luquet, Isabelle, Klein, Emilie, de Grande, Anne-Charlotte, Sarry, Audrey, Pigneux, Arnaud, Récher, Christian, Bertoli, Sarah, Dumas, Pierre-Yves
Publicado 2021

CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia

por Bertoli, Sarah, Boutzen, Helena, David, Laure, Larrue, Clément, Vergez, François, Fernandez-Vidal, Anne, Yuan, Lingli, Hospital, Marie-Anne, Tamburini, Jérôme, Demur, Cécile, Delabesse, Eric, Saland, Estelle, Sarry, Jean-Emmanuel, Galcera, Marie-Odile, Mas, Véronique Mansat-De, Didier, Christine, Dozier, Christine, Récher, Christian, Manenti, Stéphane
Publicado 2015

Dexamethasone in hyperleukocytic acute myeloid leukemia

por Bertoli, Sarah, Picard, Muriel, Bérard, Emilie, Griessinger, Emmanuel, Larrue, Clément, Mouchel, Pierre Luc, Vergez, François, Tavitian, Suzanne, Yon, Edwige, Ruiz, Jean, Delabesse, Eric, Luquet, Isabelle, Linares, Laetitia Karine, Saland, Estelle, Carroll, Martin, Danet-Desnoyers, Gwenn, Sarry, Audrey, Huguet, Françoise, Sarry, Jean Emmanuel, Récher, Christian
Publicado 2018

Outcome of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia before Second-Generation FLT3 Tyrosine Kinase Inhibitors: A Toulouse–Bordeaux DATAML Registry Study

por Bertoli, Sarah, Dumas, Pierre-Yves, Bérard, Emilie, Largeaud, Laetitia, Bidet, Audrey, Delabesse, Eric, Tavitian, Suzanne, Gadaud, Noémie, Leguay, Thibaut, Leroy, Harmony, Rieu, Jean-Baptiste, Vial, Jean-Philippe, Vergez, François, Lechevalier, Nicolas, Luquet, Isabelle, Klein, Emilie, Sarry, Audrey, De Grande, Anne-Charlotte, Récher, Christian, Pigneux, Arnaud
Publicado 2020